Αναζήτηση
Αποτελέσματα 1-5 από 5
Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control
(2011)
Background: Asthma is a chronic inflammatory airways disorder. However, no biomarker of airways inflammation has been included in the assessment of asthma control. Objective: To evaluate exhaled NO (FeNO) and exhaled breath ...
Global assessment of the COPD patient: Time to look beyond FEV1?
(2009)
COPD is a diverse disease entity with multiple dimensions that uniquely define the patient's performance, morbidity and mortality. FEV1 is both the traditional metric used to define the progression of COPD as well as the ...
Associations between BODE Index and Systemic Inflammatory Biomarkers in COPD
(2011)
Background: COPD is a multicomponent disease and systemic inflammation represents one of the possible mechanisms responsible for its systemic manifestations, including skeletal muscle weakness and cachexia. Fat-free mass ...
Plasma leptin and adiponectin in COPD exacerbations: Associations with inflammatory biomarkers
(2010)
Background: Various systemic inflammatory markers have been evaluated for their value in acute exacerbations of chronic obstructive pulmonary disease (COPD). Leptin and adiponectin have been linked to acute exacerbations ...
Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
(2011)
Endogenous airway acidification, as assessed by exhaled breath condensate (EBC) pH, is present in patients with stable COPD. The aim of this study was to measure EBC pH levels in a large cohort of COPD patients and to ...